Homeostatic chemokines increase survival of B-chronic lymphocytic leukemia cells through inactivation of transcription factor FOXO3a
- 14 May 2007
- journal article
- Published by Springer Nature in Oncogene
- Vol. 26 (50) , 7081-7091
- https://doi.org/10.1038/sj.onc.1210519
Abstract
No abstract availableKeywords
This publication has 34 references indexed in Scilit:
- Small peptide inhibitors of the CXCR4 chemokine receptor (CD184) antagonize the activation, migration, and antiapoptotic responses of CXCL12 in chronic lymphocytic leukemia B cellsBlood, 2005
- IκB Kinase Promotes Tumorigenesis through Inhibition of Forkhead FOXO3aPublished by Elsevier ,2004
- FOXO Transcription Factors as Regulators of Immune Homeostasis: Molecules to Die for?The Journal of Immunology, 2003
- Proteolytic regulation of Forkhead transcription factor FOXO3a by caspase-3-like proteasesOncogene, 2003
- ZAP-70 Expression as a Surrogate for Immunoglobulin-Variable-Region Mutations in Chronic Lymphocytic LeukemiaNew England Journal of Medicine, 2003
- Regulation of hairy-cell survival through constitutive activation of mitogen-activated protein kinase pathwaysOncogene, 2003
- Activation of extracellular signal‐regulated kinases ERK1 and ERK2 induces Bcl‐xL up‐regulation via inhibition of caspase activities in erythropoietin signalingJournal of Cellular Physiology, 2003
- An old kinase on a new path: Raf and apoptosisCell Death & Differentiation, 2002
- CD38 expression is an important prognostic marker in chronic lymphocytic leukaemiaLeukemia, 2002
- Chemokines as regulators of T cell differentiationNature Immunology, 2001